Is Grifols SA (GRFS) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 143.0% / 30% | 14.2% / 30% | 15.3% / 30% | 0.62% / 5% | ✗ NOT HALAL |
| DJIM | 143.0% / 33% | 14.2% / 33% | 15.3% / 33% | 0.62% / 5% | ✗ NOT HALAL |
| MSCI | 47.1% / 33% | 4.7% / 33% | 5.0% / 33% | 0.62% / 5% | ✗ NOT HALAL |
| S&P | 143.0% / 33% | 14.2% / 33% | 15.3% / 33% | 0.62% / 5% | ✗ NOT HALAL |
| FTSE | 47.1% / 33% | 4.7% / 33% | 5.0% / 50% | 0.62% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 38.8% | |
| Operating Margin | 17.5% | |
| Net Margin | 5.3% | |
| Return on Equity (ROE) | 6.2% | |
| Return on Assets (ROA) | 4.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $902M |
| Free Cash Flow | $531M |
| Total Debt | $10.1B |
| Debt-to-Equity | 126.8 |
| Current Ratio | 2.5 |
| Total Assets | $21.4B |
Price & Trading
| Last Close | $7.62 |
| 50-Day MA | $8.78 |
| 200-Day MA | $9.29 |
| Avg Volume | 611K |
| Beta | 1.2 |
|
52-Week Range
$6.19
| |
About Grifols SA (GRFS)
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Grifols SA (GRFS) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Grifols SA is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Grifols SA's debt ratio?
Grifols SA's debt ratio is 143.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 47.1%.
What are Grifols SA's key financial metrics?
Grifols SA has a market capitalization of $6.2B, trailing P/E ratio of 11.9, and revenue of $7.2B. The company maintains a gross margin of 38.8% and a net margin of 5.3%. Return on equity stands at 6.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.